Isomorphic Labs raises $5B Series C co-led by Greenoaks and Sequoia
SergeiIakhnin · x · 2026-11-17
Isomorphic Labs, the AI drug design company spun out of DeepMind, announced a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with a16z joining as a new investor and Alphabet continuing to invest significantly. All existing investors — Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund — participated.
The funds will scale its proprietary drug design engine (IsoDDE) and its pipeline of AI-designed therapeutic candidates.
Related event: Isomorphic Labs Raises $5 Billion to Solve All Disease with AI(6 posts)→
More from Venture
- Grok Bot Content System: Automate Research, Never Judgment — a $10K Side-Biz Play — PrajwalTomar_ · 2026-11-17
- Solo dev open-sources OpsBridge, an agent workbench for investigating blocked invoices — Fit_Fortune953 · 2026-11-17
- Anthropic's funding roadshow reportedly features just a countdown clock, no slides — morqon · 2026-11-17
- Isomorphic Labs raises $5B to accelerate AI-first drug design, says Demis Hassabis — demishassabis · 2026-11-17
- California sues OpenAI over agent incidents; Li Yanhong says AI value lies in apps — 快鲤鱼 · 2026-11-17
- Indie dev's cloud bill for Pearl Chat is so steep he jokes about a poultry farm — weskambale · 2026-11-17